Biogen Inc. (BIIB)
NASDAQ · Healthcare
Biogen Inc. Total Liabilities 2007–2025
Biogen Inc. annual total liabilities history from 2008 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Biogen Inc. total liabilities as of December 31, 2025: 11.18B, a 1.33% decrease year-over-year.
- Biogen Inc. total liabilities for 2025 were 11.18B, a 1.33% decrease from 2024.
- Biogen Inc. total liabilities for 2024 were 11.33B, a 5.91% decrease from 2023.
- Biogen Inc. total liabilities for 2023 were 12.05B, a 7.88% increase from 2022.
- Biogen Inc. total liabilities for 2022 were 11.17B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Biogen Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $11,183 |
| 2024 | $11,333 |
| 2023 | $12,045 |
| 2022 | $11,166 |
| 2021 | $12,918 |
| 2020 | $13,933 |
| 2019 | $13,895 |
| 2018 | $12,257 |
| 2017 | $11,055 |
| 2016 | $10,748 |
| 2015 | $10,130 |
| 2014 | $3,501 |
| 2013 | $3,242 |
| 2012 | $3,166 |
| 2011 | $2,623 |
Biogen Inc. Total Liabilities — FAQ
Biogen Inc. (BIIB) total liabilities over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIIB's total liabilities history?
The chart and table above show Biogen Inc.'s total liabilities by year and by quarter, including the growth rate.